Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines

Emily G. Baxi(Johns Hopkins University), Terri G. Thompson(First Point Scientific), Jonathan Li(Massachusetts Institute of Technology), Julia Kaye(Gladstone Institutes), Ryan G. Lim(University of California, Irvine), Jie Wu(University of California, Irvine), Divya Ramamoorthy(Massachusetts Institute of Technology), Leandro de Araújo Lima(Gladstone Institutes), Vineet Vaibhav(Cedars-Sinai Medical Center), Andrea Matlock(Cedars-Sinai Medical Center), Aaron P. Frank(Cedars-Sinai Medical Center), Alyssa N. Coyne(Johns Hopkins University), Barry Landin(IBM (United States)), Loren Ornelas(Cedars-Sinai Medical Center), Elizabeth Mosmiller(Johns Hopkins University), Sara Thrower(Harvard University), S. Michelle Farr, Lindsey Panther(Cedars-Sinai Medical Center), Emilda Gomez(Cedars-Sinai Medical Center), Erick Galvez(Cedars-Sinai Medical Center), Daniel I. Pérez(Cedars-Sinai Medical Center), Imara Meepe(Cedars-Sinai Medical Center), Susan Lei(Cedars-Sinai Medical Center), Berhan Mandefro(Cedars-Sinai Medical Center), Hannah Trost(Cedars-Sinai Medical Center), Louis Pinedo(Cedars-Sinai Medical Center), Maria G. Bañuelos(Cedars-Sinai Medical Center), Chunyan Liu(Cedars-Sinai Medical Center), Ruby Moran(Cedars-Sinai Medical Center), Veronica J. Garcia(Cedars-Sinai Medical Center), Michael J. Workman(Cedars-Sinai Medical Center), Ritchie Ho(Cedars-Sinai Medical Center), Stacia K. Wyman(Gladstone Institutes), Jennifer Roggenbuck(ABS Consulting (United States)), Matthew B. Harms(The Ohio State University Wexner Medical Center), Jennifer Stocksdale(University of California, Irvine), Ricardo Miramontes(University of California, Irvine), Keona Q. Wang(University of California, Irvine), Vidya Venkatraman(Cedars-Sinai Medical Center), Ronald Holewenski(Cedars-Sinai Medical Center), Niveda Sundararaman(Cedars-Sinai Medical Center), Rakhi Pandey(Cedars-Sinai Medical Center), Danica-Mae Manalo(Cedars-Sinai Medical Center), Aneesh Donde(Massachusetts Institute of Technology), Nhan Huynh(Massachusetts Institute of Technology), Miriam Adam(Massachusetts Institute of Technology), Brook T. Wassie(Massachusetts Institute of Technology), Edward Vertudes(Gladstone Institutes), Naufa Amirani(Gladstone Institutes), Krishna Raja(Gladstone Institutes), Reuben Thomas(Gladstone Institutes), Lindsey R. Hayes(Johns Hopkins University), Alex Lenail(Massachusetts Institute of Technology), Aianna Cerezo(Johns Hopkins University), Sarah Luppino(Harvard University), Alanna Farrar(Harvard University), Lindsay Pothier(Harvard University), Carolyn Prina(The Ohio State University Wexner Medical Center), Todd E. Morgan(Texas Neurology), Arish Jamil(Emory University), Sarah Heintzman(The Ohio State University Wexner Medical Center), Jennifer Jockel‐Balsarotti(Washington University in St. Louis), Elizabeth Karanja(Washington University in St. Louis), Jesse Markway(Washington University in St. Louis), Molly McCallum(Washington University in St. Louis), Ben Joslin(Northwestern University), Deniz Alibazoglu(Northwestern University), Stephen J. Kolb(The Ohio State University Wexner Medical Center), Senda Ajroud‐Driss(Northwestern University), Robert H. Baloh(Cedars-Sinai Medical Center), Daragh Heitzman(Texas Neurology), T. W. Miller(Washington University in St. Louis), Jonathan D. Glass(Emory University), Natasha Leanna Patel-Murray(Massachusetts Institute of Technology), Hong Yu(Harvard University), Ervin Sinani(Harvard University), Prasha Vigneswaran(Harvard University), Alexander Sherman(Harvard University), Omar Ahmad(Johns Hopkins University), Promit Roy(Johns Hopkins University), Jay Beavers(Microsoft (United States)), Steven R. Zeiler(Johns Hopkins University), John W. Krakauer(Johns Hopkins University), Carla Agurto(IBM (United States)), Guillermo Cecchi(IBM (United States)), Mary Bellard(Microsoft (United States)), Yogindra Raghav(Massachusetts Institute of Technology), Karen Sachs(Massachusetts Institute of Technology), Tobias Ehrenberger(Massachusetts Institute of Technology), Elizabeth Bruce(Microsoft (United States)), Merit Cudkowicz(Harvard University), Nicholas J. Maragakis(Johns Hopkins University), Raquel Norel(IBM (United States)), Jennifer E. Van Eyk(Cedars-Sinai Medical Center), Steven Finkbeiner(Gladstone Institutes), James D. Berry(Harvard University), Dhruv Sareen(Cedars-Sinai Medical Center), Leslie M. Thompson(University of California, Irvine), Ernest Fraenkel(Massachusetts Institute of Technology), Clive N. Svendsen(Cedars-Sinai Medical Center), Jeffrey D. Rothstein(Allen Institute for Brain Science)
Nature Neuroscience
February 1, 2022
Cited by 155Open Access
Full Text

Abstract

Answer ALS is a biological and clinical resource of patient-derived, induced pluripotent stem (iPS) cell lines, multi-omic data derived from iPS neurons and longitudinal clinical and smartphone data from over 1,000 patients with ALS. This resource provides population-level biological and clinical data that may be employed to identify clinical-molecular-biochemical subtypes of amyotrophic lateral sclerosis (ALS). A unique smartphone-based system was employed to collect deep clinical data, including fine motor activity, speech, breathing and linguistics/cognition. The iPS spinal neurons were blood derived from each patient and these cells underwent multi-omic analytics including whole-genome sequencing, RNA transcriptomics, ATAC-sequencing and proteomics. The intent of these data is for the generation of integrated clinical and biological signatures using bioinformatics, statistics and computational biology to establish patterns that may lead to a better understanding of the underlying mechanisms of disease, including subgroup identification. A web portal for open-source sharing of all data was developed for widespread community-based data analytics.


Related Papers

No related papers found

Powered by citation graph analysis